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Abstract

1"
Three-dimensional culture models, such as cell spheroids, are widely used in basic and translational 2" research. Since handling a high number of cell spheroids is more complex and time consuming than 3" handling monolayer cultures, we exploited laser ablation and replica molding to fabricate 4" polydimethylsiloxane (PDMS) multi-well chips for the generation and culture of multiple cell 5" spheroids. Articular chondrocytes (ACs) were used to validate the multi-well PDMS chips. well spheroids were comparable or superior to standard spheroids in terms of chondrogenic 7" differentiation. Moreover, the use of multi-well chips significantly reduced the operation time for 8" cell seeding and medium refresh.
9"
Using a similar approach, clinical-grade fibrin was used to generate implantable multi-well 10" constructs, allowing differential cell seeding in the construct structure and in the wells. fibrin constructs with high cell density regions were compared with constructs where ACs were 12" homogeneously distributed. Expression of chondrogenic genes was increased after 7 days in vitro in 13" both types of constructs, with multi-well constructs showing higher SOX9 and ACAN levels than 14" standard constructs. Through differential cell staining, we demonstrated that high cell density 15" regions can be precisely generated in multi-well constructs and that they are still detectable after 5 16" weeks in vivo.
17"
In conclusion, multi-well chips for the generation and culture of multiple cell spheroids can be 18" fabricated by low-cost rapid prototyping techniques. Furthermore, these techniques can be used to 19" generate implantable constructs with defined architecture and spatially controlled cell distribution, 20" allowing the in vitro and in vivo investigation of cell interactions in a 3D environment.
Introduction
1"
Three-dimensional (3D) cultures are widely used as in vitro models for cell culture. Compared with 2" monolayer cultures, 3D models better mimic the in vivo tissue features, thus providing a 3" physiologically relevant environment (Abbott 2003) . Among different types of 3D models 4" developed in the last years, multiple cell aggregates or spheroids have been widely used in tumor 5" (Burdett et al. 2010 ) and tissue engineering (Fennema et al. 2013 ) research areas. The screening of 6" multiple drugs or culture conditions through 3D cell spheroids requires a relevant number of 7" experimental replicates with cells from different donors, thus making the use of this 3D model more 8" complex and time-consuming compared to conventional monolayer cultures. 3D spheroids,
9"
whereby specific extracellular matrix is produced by aggregated cells, also represent the living 10"
"building blocks" in organ printing, which aims at the layer-by-layer biofabrication of 3D
11"
functional tissues and organs (Boland et al. 2003; Jakab et al. 2004; Mironov et al. 2009 ).
12"
The need to generate cell spheroids in a high throughput fashion for cancer research and for basic 13" and translational tissue engineering studies has encouraged the development of multi-well devices 14" as an alternative to standard methods for the formation and culture of multiple 3D cell spheroids 15" (Babur et al. 2013; de Ridder et al. 2000; Moreira Teixeira et al. 2012; Ratnayaka et al. 2013) .
16"
Indeed, these devices provide a relevant tool to implement 3D spheroid models, reducing the time 17" required for routine operations and minimizing differences between experimental replicates.
18"
Rapid prototyping techniques represent an exceptional tool to generate easy-handling platforms for
19"
3D cell culture. However, existing lithography-based approaches are often expensive and time 20" consuming (Whitesides et al. 2001 ). Indeed, current approaches based on lithographic fabrication
21"
require cleanroom facilities where any minor change in the design involves increasing costs related 22" to the fabrication process. Laser fabrication techniques offer an alternative to lithography-based the fabrication of micro-wells in order to minimize fabrication complexity (Napolitano et al. 2007;  25" Piraino et al. 2012; Selimovic et al. 2011) .
26"
Another key element for developing innovative 3D models is the possibility of generating scaffolds 1" with a controlled micro-and/or macro-scale architecture , directing cell distribution and/or cell 2" orientation by topographical cues (Bae et al. 2014; Gerberich and Bhatia 2013) . Implantable multi- al. 2013), demonstrating the great potentiality of this approach.
6"
In this study we exploited laser ablation and replica molding to fabricate multi-well 7" polydimethylsiloxane (PDMS) chips for the culture of multiple cell spheroids, using human the validation of platforms for 3D spheroid formation and culture.
14"
The same rapid prototyping techniques were used to biofabricate implantable fibrin multi-well
15"
constructs, allowing differential cell seeding into the construct structure and into the wells. We used
16"
a clinical-grade fibrin glue (Ahmed et al. 2008; Ahmed and Hincke 2010; Colombini et al. 2014a; 17" Scotti et al. 2010 ) to validate our biofabrication process and through differential cell staining we 18" verified the feasibility of precise cell seeding in different regions of the multi-well construct. As a
19"
proof of concept, we biofabricated fibrin constructs whereby human ACs were homogeneously 20" dispersed or where different cell density regions were generated. Then, we evaluated cell behavior 21" in standard and multi-well fibrin constructs after 1 and 7 days of in vitro culture and after 5 weeks 22" of subcutaneous implantation in nude mice.
23"
24"
Materials and Methods
25"
Cell isolation and expansion
26"
Samples of articular cartilage were harvested from patients affected by osteoarthritis undergoing 1" total hip replacement (5 males and 5 females, mean age 64±8 years), with patients' informed 2" written consent and with the approval of the Institutional Review Board. ACs were isolated from 3" cartilage by enzymatic digestion using 0.15% type II collagenase (Worthington Biochemical Co)
4"
for 22 h at 37°C, according to a previously established protocol (Lagana et al. 2014 ; Lopa et al.
5"
2013). The cells were plated at a density of 10 4 cells/cm 2 and cultured in expansion medium.
6"
Expansion medium was composed as follows: High Glucose Dulbecco's Modified Eagle's Medium
7"
(HG-DMEM, Gibco) supplemented with 10% Fetal Bovine Serum (FBS, Lonza), 1% HEPES 8"
(Gibco), 1% Sodium pyruvate (Gibco), 1% Penicillin/Streptomycin/Glutamine (Gibco), 1 ng/mL
9"
Transforming Growth Factor ß-1 (TGF-ß1, Peprotech) and 5 ng/mL Fibroblast Growth Factor 2 10"
(FGF-2, Peprotech). At subconfluence, cells were detached by 0.05% trypsin/0.53 mM EDTA
11"
(Gibco) and plated at 5×10 3 cells/cm 2 for further expansion. At passage 2, cells were frozen and
12"
stored in liquid nitrogen. When needed, cells were thawed and expanded for one additional passage.
13"
To limit the expansion phase required to obtain a suitable number of cells, cells from different
14"
donors were pooled together to perform the experiments. renderings are reported respectively in Fig. 1b and 1c .
6"
Cell spheroid formation
7"
Sterile PDMS chips were placed in a 12 well multiwell plate and each PDMS chip was seeded with 8" a total number of 2.85x10 6 cells by pipetting 1.5x10 5 cells in each single well (Fig. 1a , step III). The 9" 12 well multiwell plate was then centrifuged for 5 min at 230g to favor spheroid formation. After 2
10"
h, 2.85 mL of chondrogenic medium were gently added to each well (Fig. 1a , step IV). Control
11"
(Ctrl) spheroids were prepared in 1.5 ml screw-cap conical tubes. Briefly, 1.5x10 5 cells were
12"
suspended in 150 µL of chondrogenic medium, transferred to a tube, and centrifuged for 5 min at
13"
230g. Chondrogenic medium was composed as follows: HG-DMEM supplemented with 0.029
14"
mg/ml L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 10 mM Hepes, 1 mM sodium
15"
pyruvate, 1.25 mg/ml Human Serum Albumin (HSA, Sigma-Aldrich), 1% ITS+1 (containing 1.0
16" mg/ml insulin from bovine pancreas, 0.55 mg/ml human transferrin, 0.5 µg/ml sodium selenite, 50
17" mg/ml bovine serum albumin and 470 µg/ml linoleic acid, Sigma-Aldrich), 0.1 µM dexamethasone,
18"
0.1 mM L-ascorbic acid-2-phosphate and 10 ng/ml TGF-β1. Samples were cultured for 21 days
19"
(37°C, 5% CO 2 ). Medium was replaced twice per week.
20"
Measurement of operation time for cell seeding and medium refresh
21"
For spheroid culture in standard tubes and in multi-well PDMS chips, we measured the operation
22"
time required to perform cell seeding and medium refresh. Independent measures were obtained
23"
testing 3 operators with different skill levels in cell culture techniques.
24"
Spheroid analysis
25"
Evaluation of spheroid area
26"
After 7, 14, and 21 days of culture in chondrogenic medium, spheroids in the multi-well chips were 1"
photographed to monitor the size variation. Spheroid area was determined by image analysis using 2"
ImageJ software.
3"
Quantification of metabolic activity and DNA content
4"
After 21 days of culture in chondrogenic medium, cell metabolic activity was evaluated by Alamar
5"
Blue assay. Briefly, spheroids were randomly harvested from different PDMS chips and from the 6" tubes (control group), transferred to a 96 well multiwell plate, and incubated with 100 µL HG-
7"
DMEM supplemented with 10% Alamar Blue for 4 h at 37°C. After incubation, the supernatant was 8"
harvested and fluorescence was measured (540 nm-580 nm) using a Victor X3 Plate Reader (Perkin
Elmer). The same spheroids were lysed for DNA quantification. After washing with Phosphate
10"
Buffered Saline (PBS), spheroids were digested (16 h, 60°C) in 500 µl of PBE buffer (100 mM
11"
Na 2 HPO 4 , 10 mM NaEDTA, pH 6.8) containing 1.75 mg/ml L-cystein (Sigma-Aldrich) and 14.2
12"
U/ml papain (Worthington). DNA quantification was performed by CyQUANT Kit (Invitrogen),
13"
according to the manufacturer's instructions.
14"
Histological and immunohistochemical analysis
15"
For histological analysis, chondrocyte spheroids cultured for 21 days were fixed for 24 h in 10%
16"
neutral buffered formalin, embedded in paraffin and sectioned at 3 µm. Sections were stained with 17" alcian blue (pH 2.5, Sigma-Aldrich) to detect glycosaminoglycans (GAGs). For
18"
immunohistochemistry, sections were deparaffinized, rehydrated, and treated with 3% hydrogen developed with 3.3′ diaminobenzidine (DAB) for 5 min and sections were counterstained for 2 min
24"
with Mayer's hematoxylin.
25"
26"
Implantable multi-well fibrin constructs 1"
Fabrication of PMMA master templates and PDMS counter-molds
2"
PMMA master templates and the corresponding PDMS counter-molds were fabricated by CO2 laser 3" ablation ( Fig. 2a , step I) and replica molding (Fig. 2a , step II), as previously described for the
4"
fabrication of multi-well PDMS chips.
5"
Three different configurations of PDMS molds were designed to biofabricate fibrin constructs with (Harrick Plasma Instruments, USA) for 8 minutes to reduce surface hydrophobicity.
10"
Biofabrication of multi-well fibrin constructs
11"
The two-component fibrin sealant Tisseel ® (Baxter Biosurgery) was used to generate the fibrin
12"
constructs. The fibrinogen component contained 91 mg/mL human fibrinogen and 3000 KIU/mL 13" aprotinin solution. The thrombin component was diluted to 5 U/mL in 40 mM of CaCl 2 at pH 7.0.
14"
Initially, fibrin constructs with three different configurations of the multi-well bottom layer were the bottom layers. Then, different cell numbers were seeded in each well, depending on the density 15.4x10 6 cells/mL) and pouring the mixture over the multi-well bottom layer (Fig. 2a, step 26" V). In this phase, the PDMS ring was used to match the bottom layer shape and to avoid fibrin 1"
leaking. After polymerization, the PDMS ring was removed and constructs were cultured in 3 mL 2"
chondrogenic medium (Fig. 2a, step VI) . After selecting the best bottom layer configuration based 3"
on the reproducibility of construct fabrication and cell seeding into the wells, we compared the 4" multi-well fibrin constructs (10 wells, Ø well 1.5 mm, h well 1.5 mm, 2x10 5 cells/well) with a similar 5"
construct without wells. Both types of fibrin constructs (Ø 8 mm, h 3 mm) were seeded with a total 6" number of 4x10 6 cells. Bottom and top layer of the multi-well fibrin constructs were prepared as 7"
aforementioned. To seed the wells of the constructs, a cell suspension with a density of 10 8 cells/mL 8"
was prepared. In each well, we added 2 µL of solution, corresponding to 2x10 5 cells. To prepare
standard fibrin constructs without wells, 4x10 6 cells were suspended in fibrinogen and thrombin
10"
mixed at a 1:1 ratio (cell density 26.7x10 6 cells/mL). The mixture was poured into the custom made
11"
PDMS rings and let polymerize for 1 h at 37 o C. After polymerization, all constructs were cultured 12" in 3 mL chondrogenic medium.
13"
Fibrin construct analysis
14"
Evaluation of multi-well structure and cell distribution
15"
The macroscopic features of the different bottom layers were evaluated by stereomicroscope
16"
(Olympus SXZ10). Cell distribution into the construct and feasibility of cell seeding into the wells 17"
were evaluated by fluorescence microscopy (Olympus IX71) using green-or red-cells stained cells were suspended at a density of 1x10 6 cells/mL in serum-free culture medium. Vybrant DiO or
21"
Vybrant CM-Dil was added to the cell suspension (5 µL/mL). Cells were incubated for 10 min at twice in expansion medium prior to use.
24"
Histological analysis
25"
After 7 days of in vitro culture, fibrin constructs cultured for 7 days were fixed for 24 h in 10%
1"
neutral buffered formalin, embedded in paraffin and sectioned at 3 µm. For morphological 2"
evaluation of fibrin glue constructs, sections were stained with hematoxylin and eosin (HE).
3"
Quantification of DNA and GAGs content 4"
After 7 days of in vitro culture, fibrin constructs were digested, as previously described for 5" chondrocyte spheroids. DNA quantification was performed by CyQUANT Kit." The amount of
6"
GAGs was spectrophotometrically measured using 16 mg/mL dimethylmethylene blue (Sigma- content was normalized to the DNA content and expressed as µg GAGs/µg DNA.
9"
Gene expression analysis 10"
After 1 and 7 days of in vitro culture, fibrin constructs were harvested and stored in liquid nitrogen
11"
for RNA isolation and gene expression analysis. Total RNA was purified using RNeasy Mini kit 12"
(Qiagen) following sample disruption with TissueRuptor (Qiagen). RNA was quantified using a 13"
spectrophotometer (Nanodrop, Thermo Scientific) and reverse-transcribed to cDNA using iScript
14"
cDNA Synthesis Kit (Bio-Rad Laboratories). Gene expression was evaluated by real time PCR markers was normalized to GAPDH using the delta Ct method.
22"
Subcutaneous implantation of fibrin constructs in nude mice
23"
Fibrin constructs without or with wells were seeded with green-and red-stained cells and
24"
subcutaneously implanted in nude mice. The in vivo study was approved by the Mario Negri
25"
Institute for Pharmacological Research (IRFMN) Animal Care and Use Committee (IACUC).
26"
Animals and their care were handled in compliance with institutional guidelines as defined in Council, Statement of Compliance A5023-01, November 6, 1998).
5"
Three 6-week-old female athymic mice were obtained from Harlan provided ad libitum. Animals were anesthetized by intraperitoneal injection of ketamine chloride 8"
(80 mg/kg, Imalgene, Merial) and medetomidine hydrochloride (1 mg/kg, Domitor, Pfizer).
9"
Surgical procedures were performed in sterile conditions under a laminar flow hood. Four
10"
subcutaneous pockets were created on the dorsum of each mouse by blunt dissection through cranial
11"
and caudal skin incisions. One fibrin construct was inserted in each pocket, then the skin was
12"
sutured with #4-0 Monocryl thread (Ethicon). After 5 weeks, mice were euthanized by CO 2
13"
inhalation and constructs were explanted.
Explant analysis
15"
Evaluation of cell distribution
16"
After 5 weeks in vivo, the distribution of green-and red-stained cells in the explants was evaluated
17"
by fluorescent microscopy (Olympus IX71).
18"
Quantification of GAGs content
19"
Fibrin constructs cultured in vitro for 7 days were analyzed before and after in vivo subcutaneous 20"
implantation for 5 weeks. Samples were digested in PBE buffer and GAGs were quantified by 21" dimethylmethylene blue assay, as aforementioned. GAGs content was normalized to the construct
22"
wet weight (mg).
23"
Statistical analysis
25"
All data are presented as mean±SD. Kolmogorov-Smirnov test was used to assess the normal data chip A, spheroids in chip B) was performed by One-Way ANOVA with Dunnett's post hoc-test.
4"
Mann-Whitney test (unpaired data) for non-normally distributed data was performed to compare 5" different types of fibrin constructs at the same time point (i.e. w/ wells 1d vs. w/o wells 1d) and to
6"
compare the same type of fibrin construct at different time points (i.e. w/ wells 1d vs. w/ wells 7d).
7"
8"
Results
9"
Multi-well PDMS chips support the generation and culture of chondrocyte spheroids
10"
Multi-well chips were generated by PDMS replica molding on a laser-ablated PMMA master
11"
templates. Optical images of the fabricated multi-well PDMS chips in figure 1d show the fidelity of
12"
the multi-well arrays to the original design. As expected, the side view of the PDMS chips section
13"
revealed the conical shape of the wells (Fig. 1d , bottom panel).
14"
Articular chondrocytes were used to validate the multi-well PDMS chips as devices for the
15"
formation and culture of 3D cell spheroids. The PDMS chips were designed to fit the wells of a 12
16" multiplate, allowing the simultaneous culture of several spheroids in different experimental 17" conditions in the same plate, as shown in figure 3a , where PDMS chips immediately after cell
18"
seeding are depicted. The use of these devices significantly reduced the time required for cell
19"
seeding and medium refresh operations compared to standard spheroid culture, representing a
20"
technical amelioration in terms of work efficiency (Fig. 3b,c) . The PDMS chips, thanks to the
21"
transparency of the material, also allowed us to monitor the samples through microscopy over the
22"
entire period of culture and to measure basic parameters, such as spheroid area. As shown in figure   23" 3d, cell aggregates started to form already 24 hours after cell seeding and, after 21 days of culture,
24"
spheroids were well-formed in both PDMS chips. Spheroid area increased from 7 to 21 days of
25"
chondrogenic culture due to matrix deposition (Fig. 3e) . At the end of culture, we compared the difference in metabolic activity was observed among the experimental groups (Fig. 3f ). In the same
2"
way, the DNA content and the metabolic activity normalized on DNA of spheroids cultured in
3"
standard tubes and in PDMS chips did not differ, showing that spheroids cultured in PDMS chips
4"
were at least as viable and active standard spheroids (Fig. 3g,h ). Histological evaluation revealed
5"
that GAGs deposition, which is a key marker of chondrogenic differentiation, was comparable in
6"
Ctrl spheroids and in spheroids cultured in multi-well PDMS chips (Fig. 3i) . Lacunar structures,
7"
similar to those found in native hyaline cartilage, were observed in all the experimental groups.
8"
Analysis of type II collagen deposition by immunohistochemistry displayed a more intense staining
9"
in spheroids cultured in PDMS chips compared to standard spheroids, indicating the production of
10"
highly specialized extracellular matrix in these samples (Fig. 3j) .
11" 12"
Implantable multi-well fibrin constructs with high cell density regions support the 3D culture
13"
and re-differentiation of articular chondrocytes
14"
Multi-well fibrin glue constructs were prepared according to the scheme in Fig. 1b . The simplicity
15"
of the biofabrication process allowed us to prepare 65 multi-well constructs in a single experimental
16"
run. PMMA master templates and PDMS molds with the three different configurations (X, Y, Z)
17"
were used to generate the corresponding bottom layers (Fig. 4a) . We noticed that the configuration
18"
with 10 wells (Ø well 1.5 mm) was the easiest to fabricate and handle. Indeed, the configuration with
19"
larger wells (Ø well 2 mm) had a very thin outer border that did not allow for the easy removal of the
20"
construct from the PDMS mold. The peripheral border of these constructs tended to break during
21"
this operation (Fig. 4a, upper row) , resulting in leaking of the seeded cells into the adjacent wells.
22"
On the other hand, the configuration with smaller wells (Ø well 1 mm) was quite easy to manipulate
23"
since stiffer, but small imperfections in the fibrin bottom layer resulted in a dramatic reduction of
24"
the volume of the wells (Fig. 4a, upper row) , which challenged the reproducibility of cell seeding.
25"
Cell embedding in the bottom layer resulted in a homogeneous cell distribution (Fig. 4b, upper row, 
26"
green-stained cells) and cell seeding in the multi-wells proved also to be effective (Fig. 4b, middle 1"
and lower row). Based on the aforementioned considerations about simplicity and reproducibility of 2"
fabrication, we selected the configuration (Y) with 10 wells (Ø well 1.5 mm, h well 1.5 mm) for the 3"
prosecution of the study. The central section of the bottom layer shows the cell deposition on the 4" bottom side of each well (Fig. 4c) , demonstrating that red-stained cells were confined into the wells
5"
and that we were able to generate regions with different cell density in a single construct. The multi-
6"
well constructs were completed by adding the top layer, as shown in figure 4d , where the multi-well
array in the finalized scaffold can be observed.
8"
In figure 5a , macroscopic pictures of fibrin constructs without and with wells show that the pattern
9"
of multi-wells was still visible under the top layer (right image). In fibrin constructs without wells,
10"
cells were homogeneously distributed throughout the entire scaffold (Fig. 5b,c , left image), whereas
11"
in multi-well constructs single wells were clearly visible and hematoxylin/eosin staining showed
12"
that a cell multi-layer was present in the wells (Fig. 5b,c , right image), demonstrating once again
13"
that different cell density areas were generated in the construct. As revealed by histological
14"
analysis, poor matrix deposition and construct remodeling occurred after 7 days of in vitro culture 15" (Fig. 5c) , probably due to the high concentration of fibrinogen used in our constructs as well as to
16"
the short period of in vitro culture.
17"
After 7 days of culture in chondrogenic medium, the same number of cells was found in fibrin 18"
constructs without and with wells ( Fig. 5d ) and no significant difference in terms of GAGs content
19"
per cell between the two types of fibrin constructs was observed (Fig. 5e ). Gene expression analysis
20"
performed after 1 and 7 days of culture in chondrogenic medium revealed that both types of fibrin
21"
constructs well supported chondrocyte re-differentiation. Indeed, we observed that levels of
22"
chondrogenic markers such as SOX9, COL2A1, ACAN, and COMP increased from day 1 to day 7,
23"
with significant differences between time points for all the analyzed markers with the exception of
24"
SOX9 ( Fig. 5f-i ). Higher transcriptional levels of all the tested markers were measured in ACs 25" cultured in fibrin constructs with high cell density regions for 7 days, albeit increases with respect 1"
to constructs without wells were not significantly different ( Fig. 5f-i) .
2"
Finally, we evaluated the in vivo behavior of ACs in fibrin constructs without or with wells through diameter reduction from 8 mm to 1.5-2 mm. Surprisingly, despite the reduction in construct size,
7"
the multi-well structure was maintained, as shown in the post-implantation pictures where the high 8"
cell density areas corresponding to the wells are still visible. GAGs content was evaluated in the 9"
fibrin constructs cultured in vitro for 7 days (pre-implantation) and in the explants harvested after 5
10"
weeks of subcutaneous implantation (post-implantation). The content of GAGs normalized on
11"
construct wet weight was found to be significantly increased in both types of fibrin constructs after
12"
5 weeks in vivo, with no significant differences between the two types of fibrin constructs at any time point (Fig. 6b ).
15"
Discussion
16"
The primary purpose of this study was to generate multi-well PDMS chips supporting the formation
17"
and culture of cell spheroids and to biofabricate a multi-well fibrin construct through low-cost and
18"
easily accessible rapid prototyping techniques.
19"
Compared to standard protocols, the use of the PDMS multi-well chips significantly reduced the
20"
operation time for cell seeding and medium refresh, which are highly time-consuming factors when
21"
preparing several experimental replicates and working with many experimental groups. The
22"
possibility to culture simultaneously a maximum of 228 cell spheroids in a single 12 well multiwell
23"
plate also reduced the space required for the culture of such a high number of samples in the CO 2
24"
incubator. Furthermore, the optical transparency of the PDMS chips allowed us to monitor the
25"
process of spheroid formation and the changes in dimension and shape occurring during culture.
1"
The high hydrophobicity of PDMS (Berthier et al. 2012) , related to the low cell adhesion on this 2" material, led to the formation of well-defined chondrocyte spheroids in both the tested 3"
configurations. The comparison between spheroids generated and cultured in PDMS chips with
4"
spheroids in polypropylene tubes did not show any significant difference in terms of cell
5"
proliferation and metabolic activity. On the contrary, while deposition of GAGs was similar in the 6" different experimental groups, type-II collagen was more present in spheroids cultured in the PDMS
7"
chips compared to standard spheroids. These results indicate that the multi-well devices were able 8"
to support very well both cell viability and chondrogenic differentiation, thus representing an
appealing option for 3D cell culture. A similar approach has been used in a very recent study to
10"
produce and culture chondrocyte micro-pellets (166 cells/pellet) by Babur and co-workers (Babur et 11" al. 2013 ). In their study, the PDMS insert surface had to be chemically modified to avoid cell
12"
spreading all over the well. By contrast, in our devices the higher ratio between the number of 2005). In our system, the possibility to precisely seed each well with a specific cell population,
18"
together with the easiness of spheroid harvesting from selected wells, allows to evaluate the effect presented multi-well devices may be represented by the high hydrophobicity and porosity of PDMS
22"
which may cause the nonspecific absorption of small molecules and hence bias the biological PDMS, we performed systematic replacement of culture medium. Indeed, we did not observe any
26"
negative effect on the re-differentiation of ACs cultured in multi-well PDMS chips compared to 1" spheroids cultured in standard polypropylene tubes. However, since in the last years a number of 2"
surface treatments have been developed to prevent nonspecific absorption of molecules, such as sol- mutual influence between different cell types, multi-well PDMS chips can be used to produce a 8"
high number of mini-tissue spheroids, which represent the building blocks in organ printing 9"
approaches (Boland et al. 2003; Jakab et al. 2004; Mironov et al. 2009 ). Indeed, we found that 10"
spheroids were viable and metabolically active after a relatively long culture period and histological
11"
evaluation showed that cells were able to produce specific extracellular matrix. Finally, considering
12"
the field of cartilage tissue engineering, the low-cost multi-well PDMS chips described here could
13"
be exploited to generate a high number of autologous 3D chondral spheroids to be used in the NCT01222559).
16"
Here, to generate cell spheroids we exploited low-cost rapid prototyping techniques to fabricate 17" multi-well PDMS chips and we took advantage of centrifugal force to promote cell assembly into 18" 3D spheroids. More complex systems can also be implemented. For example, cell spheroids can be 19" generated within microfluidic devices combining the actions of fluid flow and gravity force,
20"
whereby cell trapping can be controlled modulating flow rate, cell density and seeding time (Fu et 21" al. 2014; Patra et al. 2013) . Alternatively, multiple cell spheroids can be generated using hanging
22"
drop plates which rely on gravity-enforced cell assembly (Cavnar et al. 2014; Tung et al. 2011) .
23"
This method has been recently combined with the bioprinting approach to generate uniform-sized
24"
embryoid body replacing manual pipetting with the automated printing of single cells and
25"
exploiting the gravity force to induce cell assembly (Xu et al. 2011) . All these methods represent
26"
have advantages and disadvantages and require a preliminary optimization phase, which is more or 1"
less extensive depending on the easiness of the system. Anyhow, the growing body of literature in
2"
this field is a clear indication of the wide number of applications whereby cell spheroids can be 3"
used both as 3D models or as tissue building blocks.
4"
In the second part of the study, we applied the same rapid prototyping techniques to produce a
5"
multi-well implantable fibrin construct. Considering the field of cartilage tissue engineering, we 6"
suggest that a similar configuration can be used to generate high cell density areas within the construct, leading to the formation of "chondrogenic centers" able to promote the differentiation of 8"
low cell density regions. Indeed, it has been shown that cell density affects the capability of 9"
chondrocytes to produce specific matrix and that a high cell density improves cartilaginous matrix 10" deposition in 3D scaffolds (Mauck et al. 2003; Talukdar et al. 2011 ). Since cartilage biopsies
11"
harvestable from patients are limited in size and allow the retrieval of a limited number of
12"
chondrocytes, an extensive in vitro expansion phase is required to obtain enough cells to seed a 3D
13"
scaffold with a high cell density, which implies chondrocyte de-differentiation (Giannoni and limiting the high cell density to some construct regions, acting as "chondrogenic centers", implies a
16"
reduction in the number of cells required to seed the construct, and subsequently a shorter possible differences in terms of extracellular matrix deposition.
4"
Remarkably, the construct configurations proposed here also offer the flexibility to be seeded with
5"
pre-formed cell aggregates where desired, being the dimensions of the wells compatible with those this case, the use of multi-well constructs described here would allow the controlled distribution of 8"
cell aggregates which cannot be achieved through a randomized seeding.
9"
As hypothesized for the PDMS chips, the multi-well construct produced in this study, can be used
10"
for the co-culture of different cell types that is usually performed by more standard 3D models such
11"
as spheroids (Giovannini et al. 2010; Lopa et al. 2013; Wu et al. 2012 ) and random cell dispersion cell types distributed in different construct regions.
20"
Bioprinting techniques could be exploited as an alternative to the biofabrication approach employed
21"
here to control cell distribution in 3D fibrin constructs, as reported in a recent study where human biofabrication method that we have presented here, the implementation of bioprinting would require 3"
an extensive preliminary phase to establish the optimal concentration of fibrinogen, thrombin,
4"
CaCl 2 as well as the polymerization time to obtain the desired configuration and grant proper cell 5" distribution and viability, representing a highly time-consuming phase in the biofabrication process.
6"
Regarding the behavior of fibrin constructs in vivo, we observed a dramatic size reduction of the 7"
implants after 5 weeks of subcutaneous implantation. This result has been previously reported in
8"
several short-term in vivo studies (Colombini et al. 2014b; Hwang et al. 2013; Peretti et al. 2000) 9"
and can be explained by two major features of fibrin: its tendency to shrink and its fast degradation 10"
rate (Ahmed et al. 2008; Meinhart et al. 1999; Wolbank et al. 2014) . Thanks to fluorescent cell
11"
staining, we verified that the implant size reduction did not alter cell distribution. Indeed dispersed
12"
red-stained cells and green-stained spot corresponding to the high cell density regions were clearly
13"
visible before and after subcutaneous implantation. On the other hand, when fibrin constructs were
14"
cultured in vitro for 7 days we observed a poor construct remodeling, meaning that the multi-well
15"
structure was well preserved and that cells were not able to deposit a relevant amount of 16" extracellular matrix. These observations can be explained by the short period of in vitro culture fibrin glue formulation, further stabilized by the presence of aprotinin (Meinhart et al. 1999) .
20"
Hence, since it has been shown that lower concentrations of fibrinogen are compatible with the
21"
biofabrication of patterned scaffolds (Koroleva et al. 2012) , we envision to tune this parameter in
22"
future in vitro studies in order to favor the interaction of multiple cell types seeded in different 23"
construct regions as well as extracellular matrix deposition.
24"
25"
Conclusions
1"
We have presented a cost-effective method exploitable for the fabrication of platforms for the 2"
culture of multiple cell spheroids and for scaffold prototyping. Remarkably, the proposed 3"
fabrication approach is simple and exploits economic tools, as commercial design software and
4"
desktop laser, which do not require dedicated facilities and are accessible to most research labs.
5"
These features prompting the application of this approach in basic and translational research,
6"
whereby cell spheroids and 3D constructs represent key models in drug screening studies as well as the building blocks for translational tissue engineering approaches. RNA isolation from fibrin constructs and in gene expression analysis.
13"
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